Nikhil Gopal, MD, discusses details from a case discussion of a patient with bladder cancer.
Nikhil A. Gopal, MD
Advertisement
Articles by Nikhil A. Gopal, MD
Nikhil A. Gopal, MD, discusses future research directions for the treatment of various renal cell carcinoma histologies.
Nikhil A. Gopal, MD, discusses treatment selection in second-line relapsed/ refractory metastatic urothelial cancer.
Nikhil A. Gopal, MD, discusses the nuances of treatment decision-making in advanced renal cell carcinoma.
Nikhil A. Gopal, MD, discusses the transition of treatment with TKIs to treatment with TKI/IO combinations for those with renal cell carcinoma.
Nikhil A. Gopal, MD, discusses how the phase 3 EV-302 and CheckMate 901 trials have advanced the treatment paradigm in metastatic urothelial cancer.
Nikhil A. Gopal, MD, discusses the benefit of belzutifan for patients with renal cell carcinoma.
Advertisement
Latest Updated Articles
Dr Gopal on the Significance of the EV-302 and CheckMate 901 Trials in mUCPublished: February 29th 2024 | Updated:
Dr Gopal on the Nuances of IO/TKI Selection in Advanced RCCPublished: March 7th 2024 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
Novel Targeted Agents Are Poised to Influence the MPN Treatment Paradigm: With John O. Mascarenhas, MD
3
Northwestern Medicine Surgeons Develop a Total Artificial Lung System to Keep a Patient Alive for 48 Hours After Removing Both Lungs, Enabling a Double-Lung Transplant
4
Dr Neff on the Accuracy and Feasibility of Self-Collected HPV Testing in Cervical Cancer
5